Licenses prescription drugs and markets them to wholesalers for sale to pharmacies or hospitals. A key growth driver is FeraMAX, an oral iron supplement that lacks the often unpleasant side effects of rival products.
|Founded: 1992||Chief Executive(s): Rene Goehrum||Stock Ticker: TSXV: RX|
|Website: www.biosyent.com||Head Office: Toronto|
|Growth 2007-12 (%): 355||Revenue 2012: 5,024,154||Reporting $: CAD|
|Exports as % of Sales: 2||Employees 2012: 18||Employees 2007: 7|